48P - eNOS genetic polymorphisms and cancer risk: Evidence from a meta-analysis and a case-control study of breast cancer

Date 19 December 2015
Event ESMO Asia 2015 Congress
Session Poster presentation 1
Topics Breast Cancer
Translational Research
Basic Principles in the Management and Treatment (of cancer)
Presenter Xueren Gao
Citation Annals of Oncology (2015) 26 (suppl_9): 8-15. 10.1093/annonc/mdv518
Authors X. Gao1, J. Wang1, W. Wang1, M. Wang2, J. Zhang1
  • 1Key Laboratory Of Developmental Genes And Human Disease, Ministry Of Education; Department Of Microbiology And Immunology, Medical School of Southeast University, 210009 - Nanjing/CN
  • 2Department Of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu/CN

Abstract

Aim/Background

The association between endothelial nitric oxide synthase (eNOS) polymorphisms (intron 4a/b, -786T > C and 894G > T) and cancer risk remains elusive. In addition, no studies focused on their associations with risk of breast cancer in Chinese Han population. Thus, a meta-analysis was conducted to determine the relationship between eNOS polymorphisms and cancer risk, and then a case-control study in Chinese Han population was performed to assess their associations with breast cancer susceptibility.

Methods

Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of association.

Results

The pooled analysis indicated that eNOS intron 4a/b and -786T > C polymorphisms were significantly associated with an increased risk of overall cancer. In subgroup analyses based on cancer type, the significant association was found between eNOS intron 4a/b polymorphism and prostate cancer risk, between eNOS -786T > C polymorphism and risk of prostate, bladder and breast cancers, and between eNOS 894G > T polymorphism and breast cancer risk. In subgroup analyses based on ethnicity, eNOS intron 4a/b and -786T > C polymorphisms were associated with an increased risk of cancer in Caucasians. In consistent with our meta-analysis results, a case-control study in Chinese Han population showed significant associations of eNOS -786T > C and 894G > T polymorphisms with the increased risk of breast cancer. In addition, stratified analyses based on pathological type showed that eNOS 894G > T polymorphism was only associated with risk of infiltrative ductal carcinoma. Stratified analyses by tumor stage showed that eNOS -786T > C polymorphism was only associated with the risk of tumor stage III and IV.

Conclusions

Our meta-analysis and case-control study suggest that eNOS -786T > C and 894G > T polymorphisms are associated with the increased risk of breast cancer.

Clinical trial identification

Disclosure

All authors have declared no conflicts of interest.